Clinical Trial Update: PiCCA Study (Panitumumab in Combination With Cisplatin/Gemcitabine) [Phase 2]

View source ↗

Summary

Phase 2 PiCCA trial of panitumumab with cisplatin/gemcitabine for cholangiocarcinoma has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Cholangiocarcinoma

Drugs mentioned

• CISPLATIN (cisplatin)
• Gemcitabine (Gemcitabine)
• Panitumumab (panitumumab)

Snippet

Sponsor: Hannover Medical School | Conditions: Cholangiocarcinomas | Phase 2 | Status: COMPLETED